The amplified genes with overexpression in each tumor sample groups might be the potential therapeutic targets for the specific tumor type, such as CCND1, CCNE2 for the ER group and E2F5, EIF2C2 for the PR group. The gene discussed is AGO2; the disease is neoplasm.